|
|
| Research article summary (published 6 Feb 2008): |
Comparative studies of the effects of Tabebuia avellanedae bark extract and beta-lapachone on the hematopoietic response of tumour-bearing mice.
Full Abstract
The effects of Tabebuia avellanedae (TACE), traditionally prescribed in the treatment of cancer, and the naphtoquinone beta-lapachone (beta-lap) on the growth and differentiation of granulocyte and macrophage progenitor cells (CFU-GM) were studied in Ehrlich ascites tumour-bearing mice. Myelosuppression concomitant with increases in spleen CFU-GM and in serum colony-stimulating activity (CSA) were observed in these animals. Treatment with TACE (30-500 mg/kg) and beta-lap (1-5mg/kg) reversed these effects in a dose-dependent manner. The optimal biologically active doses of 120 mg/kg TACE and 1mg/kg beta-lap prolonged life span of tumour-bearing mice, both producing the same rate of extension in the duration of survival. Toxic manifestations were produced by the higher doses of beta-lap in normal and tumour-bearing mice. In spite of similarities between treatments, TACE concentrations used to treat the animals presented no traces of beta-lap, as measured by TLC and HPLC analyses. Our findings suggest that the antitumour effect of TACE and beta-lap, acting synergistically with other factors, such as specific cytokines, may result from enhanced macrophage activation against tumour cells. In addition, it is clear from our results that hematopoietic disorders produced by tumours are an important pathological condition that must be considered in drug development.
Author information
Author/s: Queiroz, Mary L S (ML); Valadares, Marize C (MC); Torello, Cristiane O (CO); Ramos, Aline L (AL); Oliveira, Alaíde B (AB); Rocha, Fabíola D (FD); Arruda, Vanessa A (VA); Accorci, Walter R (WR);
Affiliation: Departamento de Farmacologia and Hemocentro, Faculdade de Ciências Médicas, Universidade, Estadual de Campinas, UNICAMP, CP 6111, CEP 13083-970, Campinas, SP, Brazil.
Journal and publication information
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal: Journal of ethnopharmacology (J Ethnopharmacol), published in Ireland. (Language: eng)
Reference: 2008-May; vol 117 (issue 2) : pp 228-35
Dates: Created 2008/04/21; Completed 2008/09/26;
PMID: 18343063, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Modulation by Acanthospermum australe extracts of the tumor induced hematopoietic changes in mice.
29 Apr 2002 - Euphorbia tirucalli L. modulates myelopoiesis and enhances the resistance of tumour-bearing mice.
17 Aug 2005 - Reaction of bone marrow hematopoiesis to the toxic effect of paclitaxel.
30 Jan 2008 - Cytotoxic pyranonaphthoquinones from Melloa quadrival vis (Bignoniaceae).
30 Mar 2005 - [Modification of in vitro hematopoiesis induced by addition of GM-CSF in long term normal human bone marrow cultures]
30 Mar 1991 - Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
30 Mar 1995 - Effects of multiple doses of T-2 toxin on the erythroid response capacity of mice following an extensive experimental bleeding.
30 Dec 1996 - Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: induction of colony-stimulating activity and stimulation of stem cell proliferation.
29 Nov 1983 - Granulocyte-macrophage colony-stimulating factor is not responsible for residual thrombopoiesis in mpl null mice.
30 Aug 2000 - The induction of interleukin-6 (IL-6) and colony-stimulating factors (CSFs) by FK565 and its thrombopoietic activity following in vivo administration.
30 Jan 1994
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.